Drug Discovery World
NOVEMBER 30, 2023
To demonstrate the utility of the company’s SYNTAX system in gene assembly, the 1.7 kb Influenza A hemagglutinin gene was used as a model system. It was presented by Xiaole Shirley Liu, PhD, CEO, GV20 Therapeutics, and titled: ‘AI-based target and antibody discovery from patient tumour profiles’.
Drug Discovery World
NOVEMBER 9, 2023
Advances in analytical techniques and approaches This session is made up of four presentations which include: Christian Graf, PhD, Fellow, Scientific Office, Novartis TRD Biologics, on: ‘MS-based cell bioassays: A novel tool for biotherapeutics characterisation’. The session ends with two presentations and two luncheon presentations.
Expert insights. Personalized for you.
59 
Let's personalize your content